筛查乳腺超声与数字乳腺断层摄影检出癌症的比较
本回顾性研究分析了2013年1月至2017年12月共24,787例筛查超声检查,其中21,220例(86%)同时接受了数字乳腺断层摄影(DBT)筛查。在115例经病理证实的乳腺癌中,DBT检出64例(其中9例仅DBT检出),超声检出106例(其中51例仅超声检出)。仅超声检出的癌症增量检出率为2.4/1000(51/21,220),仅DBT检出率为0.4/1000(9/21,220)。
要点
- 仅超声检出的51例癌症中96%为浸润性癌,而仅DBT检出的9例中多数为原位癌。
- DBT与超声检出癌症数量相似(47.8% vs 44.3%),超声在致密乳腺中可补充检出DBT遗漏的浸润性癌。
- 仅超声与DBT检出病灶在病灶大小、类型、肿瘤分期上差异有统计学意义(p值分别为0.0045、0.0113、0.0003、0.0153)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Review of outcomes of screening patients imaged with both digital breast tomosynthesis (DBT) and screening ultrasound (US) to compare the cancer detection rates and characteristics of cancers detected by the imaging modalities.
MATERIAL AND METHODS: This retrospective study reviewed a total of 24,787 screening US exams performed in the time period of January 2013 through December 2017. These exams were in patients with heterogeneously dense or extremely dense breast tissue. In this population, 21,220 (86%) had DBT screening mammography. These cases were further reviewed to identify any pathology-proven malignancy detected with US and/or DBT.
RESULTS: The study cohort consisted of 115 breast cancers in patients having screening US and DBT. Of the 115 cancers, 100 were invasive cancers and 15 were ductal carcinoma in situ: 64/115 were seen on DBT, 9 of which were seen only on DBT, and 106 were seen on US, with 51 seen only on US. The cancer detection rate of DBT only was 0.4/1000 (9/21,220) and 3.0/1000 (64/21,220) for those detected on DBT whether with or without additional US, with detection on US only having an incremental cancer detection rate of 2.4/1000 (51/21,220) above DBT detected malignancies. Differences in DBT-detected lesions and US only lesions when comparing median lesion size, lesion type, tumor type (invasive vs noninvasive) and tumor stage were statistically significant (p = 0.0045, p = 0.0113, p = 0.0003, and p = 0.0153, respectively).
CONCLUSION: In review of the outcomes of a screening US program, we found a similar number of breast cancers were detected by DBT and US, and US alone (47.8% vs 44.3%, respectively). Ninety-six percent of the cancers detected by US alone were invasive; 89% of those seen on both modalities were invasive, while most of the breast cancers seen on DBT only were in situ carcinoma. Statistically significant differences between DBT and US, and US alone were found for many lesion characteristics including lesion size, type, tumor size, and tumor stage.
引用
- Destounis S, Arieno A, Santacroce A, et al. Comparison of Cancers Detected by Screening Breast Ultrasound and Digital Breast Tomosynthesis. Acad Radiol. 2021. PMID: 33589308. doi:10.1016/j.acra.2021.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。